SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Chanson Frederic

(Last)

(First)

(Middle)

1635 VILLAGE CENTER CIRCLE, SUITE 250

(Street)

LAS VEGAS

89134

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/19/2008

3. Issuer Name and Ticker or Trading Symbol
CardioVascular BioTherapeutics, Inc. [ cvbte ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,978,750	D
Common Stock	795,282	I	Held through brokerage accounts for the Reporting Person
Common Stock	530,017	I	Investment Manager of foreign mutual funds⁽¹⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Warrant	01/25/2008	01/25/2013	Common Stock	200,000	$1	D
Warrant	11/06/2007	11/06/2012	Common Stock	200,000	$1	D
Warrant	10/12/2006	10/12/2011	Common Stock	3,700,000	$1	I	CEO of FirmInvest AG⁽²⁾

Explanation of Responses:

1. Reporting Person has investment and voting control over shares held in British Virgin Islands mutual fund as the Investment Manager.

2. Reporting Person is the CEO of FirmInvest AG which holds the warrant in trust for various clients; the warrant to purchase 1,550,000 shares of Common Stock is attributed to the Reporting Person; the warrant to purchase 2,150,000 shares of Common Stock is attributed to the various clients for which FirmInvest holds investment control.

	/s/Vincent J. Roth, attorney-in-fact for Frederic Chanson	05/28/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.